Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies

The clinical hold comes days after Intellia voluntarily paused enrollment and dosing in the same two studies.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top